Dr Katims on the Feasibility of scRNA-seq in FGFR3+ Upper Tract Urothelial Carcinoma
Andrew Katims, MD, MPH, discusses the feasibility of using single-cell RNA-sequencing in FGFR3-mutated upper tract urothelial carcinoma
Source: onclive.com
Andrew Katims News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andrew Katims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andrew Katims Today - Breaking & Trending Today
Dr Katims on the Goal for Investigating the Immune Phenotype of FGFR3+ Upper Tract Urothelial Carcinoma
Andrew Katims, MD, MPH, discusses the rationale for investigating immune responses in the tumor microenvironment of FGFR3-mutated upper tract urothelial carcinoma using single-cell RNA-sequencing.
Source: onclive.com
Dr Katims on Characterizing Immune Phenotype in FGFR3-mutated Upper Tract Urothelial Carcinoma
Andrew Katims, MD, MPH, discusses research characterizing immune responses in the tumor microenvironment of FGFR3-mutated upper tract urothelial carcinoma using single-cell RNA-sequencing
Source: onclive.com
Dr Katims on the Utility of the MSK-ACCESS Assay in Node+ MIBC
Andrew Katims, MD, MPH, discusses the utility of a circulating tumor DNA assay (MSK-ACCESS) in patients with node-positive muscle-invasive bladder cancer.
Source: onclive.com